Search

Jazz Pharmaceuticals PLC

Затворен

СекторЗдравеопазване

247.86 -3.33

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

246.26

Максимум

256.48

Ключови измерители

By Trading Economics

Приходи

-100M

193M

Продажби

139M

1.2B

P/E

Средно за сектора

17.558

57.002

EPS

4.89

Марж на печалбата

15.956

Служители

2,890

EBITDA

-126M

418M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+11.57% upside

Дивиденти

By Acuity

Следващи печалби

4.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

768M

17B

Предишно отваряне

251.19

Предишно затваряне

247.86

Настроения в новините

By Acuity

34%

66%

79 / 340 Класиране в Healthcare

Jazz Pharmaceuticals PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.08.2026 г., 22:46 ч. UTC

Jazz Pharmaceuticals PLC shares advanced in after-market trading, diverging from broader market trends that closed lower amid rising crude oil prices.

10.08.2026 г., 19:56 ч. UTC

Event
Social Media
News

Jazz Pharmaceuticals PLC to acquire Actio Biosciences for $820 million, enhancing its rare epilepsy portfolio. Shares are higher despite earlier session pullback.

7.08.2026 г., 19:36 ч. UTC

Jazz Pharmaceuticals shares are higher today, reflecting broader market gains amid expectations the Federal Reserve may pause interest rate hikes.

6.08.2026 г., 19:21 ч. UTC

Jazz Pharmaceuticals PLC shares are lower today, despite earlier gains. Mixed economic signals contribute to cautious sentiment ahead of the non-farm payrolls report.

5.08.2026 г., 19:36 ч. UTC

News

Shares of Jazz Pharmaceuticals PLC are lower today, despite earlier gains. The company raised its full-year revenue guidance, driven by strong performance from Xywav.

4.08.2026 г., 20:04 ч. UTC

Social Media
News

Jazz Pharmaceuticals PLC shares rise as analysts upgrade price targets, following strong Q2 results that beat revenue estimates and boosted 2026 sales guidance.

3.08.2026 г., 23:02 ч. UTC

News

Jazz Pharmaceuticals reported Q2 revenues of $1.208 billion, exceeding expectations. Shares advanced in after-market trading following the raised full-year guidance.

31.07.2026 г., 23:21 ч. UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30.07.2026 г., 19:59 ч. UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29.07.2026 г., 18:26 ч. UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28.07.2026 г., 23:46 ч. UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27.07.2026 г., 19:37 ч. UTC

Social Media

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24.07.2026 г., 20:07 ч. UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21.07.2026 г., 19:02 ч. UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20.07.2026 г., 23:36 ч. UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

Сравнение с други в отрасъла

Ценова промяна

Jazz Pharmaceuticals PLC Прогноза

Ценова цел

By TipRanks

11.57% нагоре

12-месечна прогноза

Среден 286.19 USD  11.57%

Висок 315 USD

Нисък 229 USD

Според 17 анализатори от Wall Street, предложили 12-месечна ценова цел за Jazz Pharmaceuticals PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

17 ratings

16

Купи

1

Задържане

0

Продай

Настроение

By Acuity

79 / 340 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

help-icon Live chat